Variants Change News Today

Mandates, that does not like vaccine mandates. but we have seen a ton of monoclonal antibodies distribute there had and now the ones that the hospitals have dont even work on omicron and the new formula is in short supply. what do we need most? >> one of the things that would help a lot is if the fda was able to complete its analysis of the protoyas inhibitor that was produced by pfizer, which has excellent safety and efficacy and would be a good replacement for monoclonal antibodies. and wouldn...